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1. Introduction 
Maxillary and mandibular bone loss has long been a challenge to dental surgeons who seek 
to reconstruct these lost segments. These lesions lead to deformation of some maxillary and 
mandibular areas which interferes in the functional rehabilitation process of these 
structures. The most common cause of these lesions is prolonged use of total prostheses in a 
large part of the Brazilian population and the searches for surgical techniques and bone 
substitutes are today proposed and studied by the academic class. In this context, Brazil is 
starting to distribute allogeneic tissue obtained, processed and qualified by musculoskeletal 
tissue banks. Such banks already have experience in dispensing tissue to the orthopedic 
area, which has been using reconstructive techniques with allografts for many years. The 
first studies proposing the use of bone substitutes for replacement of these faulty parts 
commenced in the decades subsequent to 1860. (Carrel, 1912;Groves, 1917; Sharrard, Collins, 
1961; Urist, 1965; Fischer, 1998; Tomford, 2000). 
After the verification of the disadvantages in the use of autologous tissues for this purpose, 
such as the increase in donor morbidity, greater risk of nerve lesion and of infection inherent 
to the second surgical procedure and limitation in the availability of the tissue in quantity 
and variety, the use of homologous tissue became another option that was gradually 
indicated (Cunningham, Reddi, 1992; Tomford, 2000). 
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The good results with the clinical application of allografts in dentistry motivate their use on 
an increasing scale, until in 2005 Dentistry came into the scene with the use of tissues in 
maxillary and mandibular pre-prosthetic surgery. A consensus between the National 
Transplant System and the Federal Board of Dentistry allows the use of allografts by 
specialists in the areas of Implant Dentistry, Periodontics and Oral and Maxillofacial. The 
tissue banks, in turn, prepare a tissue processing line geared toward dental needs with a 
focus on quality control and traceability. 
Thus usage has become both abrupt and a tendency in the last 5 years (RBT, 2006-2010). In 
spite of a significant number of bone transplants in the dental area with good clinical results, 
the dental profession is still lacking information about activities that involve the area of 
tissue banks, particularly in the rigid quality control and traceability. Such activities are 
founded on international standards2, literature3 and legislation4 and implemented according 
to Good Manufacturing Practice- GMP.  
We consider it very important to gather epidemiological data on bone transplants in 
dentistry, elucidating the size and the limits of this type of treatment that is already 
considered a tendency in our field. In addition, to report on our perspectives of 
investigation into the efficacy and safety of the use of allografts, with tests that can enable us 
to expand our knowledge about the osseointegration of allografts. In other words, 
knowledge that allows us to reach what we consider most important in dental treatments: 
the predictability of treatment. 
2. Bone tissue 
Bone tissue is composed of two portions: 1. Organic, consisting of intrinsic bone cells 
(osteoblasts, osteoclasts and osteocytes) and the organic matrix synthesized thereby; 2. 
Inorganic, consisting of hydroxyapatite, deposited amorphously in an initial phase and that 
in a short space of time is converted into another crystalline hydroxyapatite. Organic matrix 
corresponds to 35% of the bone volume and inorganic matrix to 65%.  
In spite of the resistance and hardness, bone tissue is very plastic and has a high capacity to 
remodel through various situations to which it is submitted, such as fractures, lesions and 
bone loss. The bone tissue regeneration process starts from important biological reactions, 
triggered by the actual tissue lesion. Grafting triggers a mechanism of migration of the bone 
cells belonging to the receptor bed to the inside of the graft, with the purpose of resorbing it 
and replacing it with neoformed bone.  
                                                                          
2European Association of Tissue Banks. Common Standards for Tissues and Cells Banking: Berlin: 
European Association of Tissue Banks; 2004. 
American Association of Tissue Banks. Standards for Tissue Banking. 11th ed. McLean : American 
Association of Tissue Banks; 2007 
3Phillips GO, Strong DM, Versen RV, Nather A.  Advances in Tissue Banking. Vol. 4. World Scientific . 
New Jersey, 2000. 
Bancroft JD, Stevens A. Theory and practice of histological techniques. Fourth Edition. Churchill 
Livingstone.  United Kingdom, 1999. 
4Law n.9434 of February 5, 1997; Decree n.2268 of June 30, 1997;Administrative Ruling n.1686 of 
September 20, 2002; Resolution n. 220 of December 27, 2006; Administrative Ruling n. 2600 of October 
21, 2009. 
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The cells belonging to the bone tissue are the osteoblasts, osteocytes and osteoclasts. 
The osteoblasts are cuboid, elongated cells of mesenchymal origin that are located in the 
bone margins; their function is to produce the organic matrix of the bone tissue. In reduced 
activity these cells assume a more slender shape. The osteocytes are encapsulated 
osteoblasts, which after maturation became imprisoned inside the mineralized matrix, but 
that still maintain contact with other cells through cytoplasmic ramifications, thus 
maintaining physiologic functionality of the tissue (Junqueira, Carneiro, 1999; Davies 2000). 
This contact with surface cells such as the osteoblasts and lining cells is related bone 
structure maintenance and to the physiological responses that lead to tissue formation or 
resorption (Aubin et al., 2006). 
The osteoclasts are giant cells with multiple nuclei and their function is related to resorption. 
In synergy with the osteoblasts they promote bone remodeling. 
The interaction and the synergism among bone cells is called creeping substitution, and this 
occurs through three essential cellular events: osteogenesis (cellular event that favors the 
synthesis of bone matrix by the osteoblasts), osteoinduction (ability to induce the migration 
of mesenchymal cells and their differentiation into osteoblasts) and osteoconduction (ability 
of the tissue to serve as a mold or guide for the cellular processes involved in bone tissue 
repair). 
Moreover, as is the case with others, the bone cells pass through the stages of the cell cycle, 
which range from formation to cell division (mitosis). Mitosis is susceptible to external 
interferences, and the cell can either enter a state of rest or continue to split cyclically (Urist, 
1965; Enneking et al., 1975; Junqueira, Carneiro, 1999; Perren, Claes, 2002). 
3. Bone transplantation 
The term transplant is not widely used by the dental community to refer to the use of bone 
tissue. The common term is bone grafting. The bone graft can receive a nomenclature and be 
classified according to the origin of its obtainment and on the implant site (Table 1). 
 
Autologous graft or autograft 
Graft of tissue from one site to another in the same 
individual 
Isograft 
Graft between people with the same genotype 
(homozygotes; e.g. identical twins) 
Allograft or homologous graft 
Graft between individuals of the same species with 
disparate genotype 
Xenograft or heterologous graft 
Graft from one individual of a species onto a  
different species 
Table 1. Classification of grafts according to their nature. Source: Drumond, 2000 
4. Clinical application of grafts over the years 
The use of bone tissue for replacement of bone losses is not a recent procedure. Since last 
century there have been accounts of the use of these tissues in humans and in experiments 
with animals as a means of assessing their efficacy. 
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In these studies, many treatments with the use of bone grafts of autologous and homologous 
nature have been proposed over the years. The first homologous bone transplant is 
described by William MacEwen in 1878 (Giovani, 2005). At this time the treatment of 
osteomyelitis was performed by means of surgical resections of the infected segments. 
Homologous tibial segments (obtained from patients submitted to osteotomies) were used 
in the reconstruction of a bone defect caused by the resection of part of the humerus of a 
young man suffering from osteomyelitis (Tomford, 2000). Encouraging results of the 
consolidation of the bone graft with the receptor bed (MacEwen, 1909) motivated 
researchers back then. In this period, there was no consensus about which bones can 
specifically be used for transplantation. Tissues were obtained randomly from donors that 
were victims of fractures, resections and amputations. For the storage and processing of 
these tissues, professionals used protocols and equipment that today are not the best suited 
to this purpose (Tomford, Mankin, 1999; Tomford, 2000). Nowadays a large portion of these 
studies has only historical value with respect to the pioneer spirit of these researchers.  
The clinical use of allografts during this period was in low demand, and occurred on an 
experimental basis at some centers from all around the world. With the availability of 
antibiotic therapy, changes occurred in the indication of these tissues, and patients with 
osteomyelitis were then submitted to pharmacological treatments, to the detriment of 
surgical procedures (Tomford, 2000). Thus surgical resections of infected segments cease to 
be a priority, and allografts are then used in the reconstructions of bone defects caused by 
tumor resections. This change causes the studies from the time to evolve as well, and to give 
more detailed accounts of the cellular processes involved in the osseointegration of grafts. 
The consensuses of these first studies serve as guidelines for the first grafts performed at 
that time.  
The use of cryopreserved allografts presents some advantages over autologous tissue, such 
as the availability of the necessary quantity of tissue and a decrease in postoperative 
morbidity. As regards morphology, there are some differences in the vascularization process 
of the cortical and spongy bone grafts. In the cortical bone, the repair is started by the action 
of osteoclasts and in the spongy bone, by the osteoblasts. Another difference lies in the 
revascularization time, which is slower for cortical bone and faster for spongy bone.  
At that time, Urist (1965) was already describing that the osteoprogenitor cells responsible 
for the bone repair process are derived from monocytes, present in an elevated number in 
the repair zone coming from the bone marrow, and that the osseointegration of grafts is 
achieved, since primitive cells not yet differentiated can differentiate into viable osteoblasts 
from osteoinductive substances. Perivascular mesenchymal cells disaggregate and migrate 
to the grafting area, where they reaggregate, proliferate and differentiate to form new bone. 
(Urist et al, 1983) 
Some substances secreted by certain cell types interfere in or even modulate the cellular 
processes of osseointegration, today known as Cytokines or growth factors.  
Urist made important discoveries in this area back in 1965, even proposing a new bone 
processing procedure aimed at the removal of a calcified layer (demineralization) from the 
matrix, making this graft more osteoinductive. At the time this kind of tissue was called 
Demineralized Bone Matrix (DBM), and the name is still in use today. Later, it was 
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understood that part of this capacity is the responsibility of the superfamilies of proteins 
(TGF), including the morphogenetic protein (BMP) present in the bone matrix. (Malafaya et 
al, 2002). 
The decade of 1980 was marked by the advent of the acquired immunodeficiency syndrome 
(AIDS) that gives rise to discussions on the safety of the clinical use of homologous tissues. 
The biological risk of disease transmission between tissue donors and recipients is the topic 
of greatest relevance and importance in the period. The tissue banks existing at that time 
were encouraged to review donor selection protocols with the objective of avoiding the 
transmission of these diseases. This encouragement was provided mainly by the 
international public health regulatory agencies, such as the FDA (Food and Drug 
Administration) and other institutions related to the Haemovigilance and tissue 
transplantation systems. The result was a standardization of the internal processes of banks 
with respective preparation of standards by the main global tissue bank associations 
(American Associating of Tissue Banks - AATB and European Association of Tissue Banks- 
EATB), which contributes to the gain of quality of tissue made available by these services 
(Nather, 1991; Galea, Kearney, 2005; Santos, 2007). 
With the availability of more reliable grafts by the tissue banks, their use, biological 
behavior and indication by surgeons become a viable treatment option. (Santos, 2011).  
Similar to the repair process in fractures and in the development of the musculoskeletal 
system, the osseointegration of grafts takes place after a selection of primordial cells that are 
differentiated into osteoblasts under the influence of osteogenic factors. (Thies et al., 1992). 
The main objective expected in the use of grafts is the ability to selectively induce the 
primordial events of the integration process, such as osteoinduction, osteoconduction and 
osteogenesis (Lindhe et al., 1997). 
According to Tomford and Mankin (1999), for cortical bone grafts to be incorporated into 
the receptor bed, there must be revascularization of this bed. When this process does not 
occur, the repair area loses balance in resorption and the graft might suffer fatigue fractures. 
Spongy grafts are consolidated more quickly.  
Boldt et al. (2001) evaluate the use of frozen bone graft in 173 acetabular reconstructions and 
79 femoral reconstructions in humans. Femoral heads obtained from a local bone bank are 
particulated and impacted in the faults. After a mean follow-up period of four years, they 
report acetabular clinical stability in 97.2 % of the cases, graft incorporation in 74% in the 
acetabula and 61% in the femurs, according to radiological analysis. They conclude that the 
results obtained with the use of impacted grafts are promising, except for the reconstruction 
of type III acetabular defects, where a reinforcement cage is recommended. 
Janssen et al. (2001) studied the use of homologous cortical rings obtained from femoral 
diaphysis for reconstruction of intervertebral discs of the lumbar spine in 137 patients. The 
results show that arthrodesis was achieved in 94% of the cases and they do not report signs 
of resorption. 
Weyts et al. (2003) analyze samples of femoral heads collected after the primary arthroplasty 
of two human donors. The tissues are cryopreserved at - 80 °C for a minimum period of six 
months, according to the protocols of the American and European Tissue Bank Associations. 
After this period, these tissues are biopsied and submitted to cell culture (for survival 
observation) and PCR (polymerase chain reaction) for genetic screening. The results show 
the presence of live cells belonging to the donors in the analyzed samples. 
www.intechopen.com
 Current Frontiers in Cryopreservation 
 
42
Lavernia et al. (2004) researched the adoption and use of allografts by orthopedic surgeons 
in 340 U.S. hospitals. The frozen graft from tissue banks certified by the American 
Association of Tissue Banks - AATB is used the most often by orthopedists for the treatment 
of knee and hip bone loss. 
Schreurs et al. (2005) conduct a study to evaluate the use of homologous bone graft from a 
tissue bank in the reconstruction of 33 femoral defects. Bone graft impaction precedes the 
fixation of the femoral nail. After a minimum follow-up of eight years there is functional 
improvement of the joint according to the Harris hip score (from 49 to 85 points from pre- to 
postoperative period) and good survival according to the Kaplan-Meier method. Although 
four patients have had femoral fractures, the authors conclude that the graft impaction 
technique and use of cemented femoral nail results in excellent survival for eight to thirteen 
years. 
Cabrita (2007) studies the treatment of infected hip arthroplasties with and without the use 
of the antibiotic-impregnated cement spacer. For the reconstruction of bone stock, Cabrita 
uses the massive particulated homologous graft in 60.9% of the patients treated and does 
not report complications related to their use. 
In a review of concepts, Giannoudis et al. (2005) emphasize the advantages of the use of 
bone grafts in the area of orthopedics and traumatology. They describe the cellular events 
present in literature that involves the osseointegration process of autologous, homologous 
grafts and of biocompatible synthetic substitutes. They stress the osteoinductive 
characteristic of fresh grafts and the osteoconductive characteristic of frozen and lyophilized 
grafts. Heyligers and Kleim (2005) verify the presence of live cells with growth potential in 
samples of femoral heads cryopreserved at - 80 ºC, over a minimum period of six months. 
The authors stress the importance of discussing the osteoconductive potential of grafts and 
highlight the need to investigate the role of these surviving cells from the frozen tissue in the 
bone formation process after its implantation. Besides the bone cells, other cells and 
inflammatory factors play a vital role in the bone repair process. The macrophages and 
substances such as interleukin one, six, eleven (IL-1, IL-6, IL-11), RANKL and 
osteoprotegerin (OPG) are found during the first three days after the lesion (Gerstenfeld, 
Einhorn, 2006). As far as macrophages are concerned, Knighton et al. (1982) explain that 
these cells are present in the repair zone and are capable of producing growth factors, 
which, in turn, stimulate the neovascularization, proliferation and migration of other cell 
types, such as the fibroblasts. 
5. Evolution of musculoskeletal tissue banks in Brazil 
Considering the satisfactory results in the use of allografts obtained from multiple donors of 
organs and tissues with brain death besides studies showing revascularization, 
osteointegration and bone formation at sites of graft ( Barros Filho, et al., 1989; Croci et al., 
2003, Zhang et al., 2004; Dallari et al., 2006, Bitar et al, 2010), an increasing number of 
orthopedic surgeons and dentists currently opt to use of homologous grafts in our country. 
This fact is corroborated by the disadvantages already known in the use of autologous 
tissues, such as the increase in postoperative morbidity, greater risk of infection inherent to 
the second surgical procedure required for their obtainment, risk of nerve lesion and 
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limitation of the quantity and variety of graft obtained (Smith et al. 1984; Cunningham, 
Reddi, 1992; Drumond, 2000). 
This tendency, combined with the growing number of patients with bone loss that seek 
specialized orthopedic and dental services, leverages the creation of some Tissue Banks in 
the country in an experimental manner. 
In Brazil, the standardization of Musculoskeletal Tissue Banks is linked to specific laws of 
our country. We have a General Coordination Office for the National Transplant System – 
SNT of the Ministry of Health that discusses and prepares, together with technical 
chambers, legislations involving the use of tissue by the medical and dental community. The 
guidelines are based on protocols already developed by some centers and on the standards 
of international associations (European Association of Tissue Banks - EATB and American 
Association of Tissue Banks-AATB). The creation of the first reference centers in the large-
scale capture, processing and distribution of musculoskeletal tissue and some of these 
experiences are described. (Amatuzzi et al., 2000, Amatuzzi et al., 2004). Tissue Banks in 
Brazil are controlled by the General Management of Blood, other Tissues, Cells and Organs - 
GGSTO of the National Health Surveillance Agency - ANVISA, an institution similar to the 
U.S. FDA. This agency focuses its activities on health surveillance and on quality control, 
traceability, appraisal of risks and of adverse effects involving tissue transplants in the 
country and its guidelines are published in the form of legislation5 that also defines 
Musculoskeletal Tissue Bank as “the service that, with physical facilities, equipment, human 
resources and adequate techniques, has as its duties the performance of clinical, laboratory 
and serological triage of tissue donors, the removal, identification, transportation, 
processing, storage and delivery of bones, soft tissues (cartilage, fasciae, serous membranes, 
muscle tissue, ligaments and tendons) and their derivatives, of human origin for therapeutic 
purposes, research and teaching”. 
6. Activities of a musculoskeletal tissue bank 
The description of activities of a musculoskeletal tissue bank is summarized in the algorithm 
below ( Illustration 01). 
Every activity related to the bank should also be based on the ethical principles inherent to 
the activities of any organ transplantation. They are: 
 Autonomy and self-determination: The recipient of tissue from the musculoskeletal 
system should be provided with information in accessible language about the entire 
tissue obtainment process, the risks and the chances of success or failure of the 
treatment. The following stage is the patient's decision, after their evaluation of the 
information received, set out in an informed consent form.  
Professionals with specific training provide all the required information, using 
language exempt from complex or technical terms, enabling the patient to achieve easy 
understand in order to make the final decision. For this document to be authentic, the 
consent must be free, that is, not caused by coercion. The professionals of a 
musculoskeletal tissue bank should be objective and impartial while providing 
guidance to recipients. Every process is recorded in the Recipient’s Form.  
                                                                          
5Administrative Ruling no. 211, of March 24, 2003 
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Illustration 01. Algorithm of the Musculoskeletal Tissue Donation and Transplantation 
Process  
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 Justice – The principle of equal opportunities for the use of available tissues. The 
definition of ethical parameters in distribution is imperative. 
 Symbolism of the body – This principle is employed mainly in the reconstruction of 
the deceased donor’s body after removal, which should be performed carefully, with 
the apparent anatomical parameters respected, thus ensuring that the family receives a 
body in adequate conditions. 
7. Obtaining musculoskeletal tissues 
The main source of musculoskeletal tissues is the notification of deceased donors to the 
Transplant Centers, Organ Service Services, and Hospital Transplant Departments. The 
teams that receive the organs and tissues are only notified after a series of procedures and 
exams has been carried out to ascertain brain death and obtain the family’s consent for the 
process of organ and tissue donation. Brain death is initially verified by a neurologist, using 
techniques of physical and imaging (doppler) exams, which are repeated after six hours in 
the presence of a family member of the potential donor. Once there is no doubt as to the 
irreversible diagnosis of brain death, the family members are asked whether they would 
consider donating their loved one’s organs. The family interview is done by trained 
members belonging to an intra-hospital committee, or by an organization that looks for 
organs. The entire donation process should be recorded and legally signed before the teams 
are notified to remove each organ (heart, liver, kidney, pancreas, lung, intestine) and tissues 
(osteochondral and fascial-ligamentous, skin, vessels, cornea, heart valves). Each team 
should have clearly-defined criteria for selecting, and at the time of notification, accepting or 
refusing the donor in question. 
For donors of musculoskeletal tissue, the selection follows a rigorous control process, with 
serological tests for antigens and HIV antibodies, Hepatitis A, B and C, HTLV-1 and 2, 
Syphilis, Chagas disease, Toxoplasmosis and Cytomegalovirus, as well as state-of-the-art 
tests for evidenciation of D (Nucleic Acid Amplification – NAT) HIV and Hepatitis B and C, 
bone marrow aspirate smear of the sternum and iliac crest sample, both for 
histopathological investigation. 
Donors with the following criteria were excluded: orthopedic pathologies, such as 
osteoporosis, osteonecrosis, rheumatoid arthritis, lupus erythematosus, neoplasias, age 
group that compromises that characteristics of the tissues, blood transfusions, tattoos or 
piercings within the period of the immunological window, use of illegal drugs, travel to 
endemic zones, generalized or localized infections, fractures, open sores on the limbs from 
which the musculoskeletal tissues are to be removed, or any other situation that places in 
doubt the quality of these tissues, pursuant to the Brazilian legislation. 
The whole procedure is carried out in totally antiseptic conditions, just as in surgery. Special 
gowns made from synthetic material are used, and all the surgical stages of antisepsis are 
followed. 
The removed tissues are immediately packaged in triple packaging, hermetically sealed, and 
delivered, under refrigeration (-4ºC) to the Tissue Bank.  
A very important stage of the capture process is donor reconstruction. The body should be 
delivered to the family free from any deformation and as close as possible to its appearance 
before the tissue removal. This is because the fear of deformation has been one of the main 
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causes of refusals of bone donation by the family. For a perfect reconstruction the 
professionals use prostheses especially developed for this purpose, plaster, sutured and 
gauze. (Illustration 02). This rigorous reconstruction is the most laborious stage in the 
removal procedure. Areas possibly visible during the funeral (face, anterior side of arm, 
anterior side of shoulder, etc.) are not approached. All the anatomical parameters are 
respected, and therefore donor deformation does not occur. 
 
Illustration 02.Limbs reconstructed with prostheses after tissue removal. 
8. Processing the musculoskeletal tissues 
Once the tissues and organs have been obtained, they are delivered to the BTME in portable 
refrigerators, with temperature monitoring throughout the transport process. The 
processing stage is preceded by a planning of the activities necessary to accomplish it, such 
as provision of materials and instruments, summoning the processing team, defining the 
preparation and dimensions, according to the needs of the service (waiting list) and requests 
for orthopaedic and odontological surgeons. This stage is done in a special, classified 
operating theater (class 100 or ISO 5) equipped with a laminar flow module. (Illustration 03). 
A Class 100 room means it has purity of 100 particules per m3 of air. For the purposes of 
comparison, an operating theater should have 10,000 particles/m3 of air. 
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Illustration 03. Classified processing room (100 particles/m3 air: Class 100/ISO 5; HEPA 
Filters 99.9 %) 
The room also has a pass-through anti-chamber, and all the environments have rigorous 
control of air particles and positive pressure, to ensure the quality of the tissues processed in 
it. Specific gowning of the professional team is also necessary, using only non-fabric 
clothing (Spunbond - Meltblown – Spunbond - SMS) to prevent the dispersion of particles 
given off by conventional cotton clothing. (Illustration 04) 
In addition to non-fabric gowning; the team must also adopt certain behaviors. For example, 
sudden movements, use of cosmetic products and exposure of the skin should be avoided 
while in this room. Adequate conduct is ensured through special training, not only for the 
processing team that actually carries out the procedure, but also for other professionals who 
enter the environment (e.g. for cleaning and maintenance purposes). 
A BTME carries out various types of tissue, for use in orthopedic and odontological surgery, 
and each procedure requires careful planning. (Illustrations 05 ,06 and 07) 
For the processing of fresh, frozen tissues, a process called mechanical processing is carried 
out, i.e. removal of the adventitious tissues such as the blood, periosteum, subcutaneous 
tissue, muscles, fasciae, and fibrotic tissue.  
The fragments are then submitted chemical processing, where they are immersed in 
hydrogen peroxide based emulsifying solutions and alcoholic solutions under ultrasound 
stirring. (Illustrations 08 and 09) 
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Illustration 04. Specific gowning to work in the classified room. 
   
Illustration 05 and 06. Processing of grafts for use in odontological surgery. The photograph 
on the left shows modeling of maxillary bone defects based on a resin prototype. The one on 
the right shows fragments of allografts for use in odontological surgery. 
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Illustration 07. Modeling of a jaw bone from a segment of proximal femur. 
 
Illustration 08. Ultrasound washing in emulsifying solution. 
www.intechopen.com
 Current Frontiers in Cryopreservation 
 
50
 
Illustration 09. Processing Team at work. 
Immediately afterwards, samples of bone marrow from the long bones and fragments of 
each tissue submitted to processing are collected from these resulting solutions, and 
submitted to microbiological processing (general culture, anaerobic and fungal culture) 
using the direct inoculation technique. Samples are also obtained for histopathological 
analysis.  
Finally, the packaging procedure is begun for all the grafts processed, which are measured 
(length, height, diameter, weight volume, perimeter), packed in sterile, triple packaging, 
vacuum sealed, and duly labeled as analysis tissue. (Figure 8). The tissues are labeled with 
the following information: donor, exams carried out, batch number, item, validity period, 
type of conservation, and bar code.  
 
Illustration 10.  Vacuum sealing and labeling. 
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Once they have been labeled, the tissues are submitted to radiography at the BTME, then 
sent for cryopreservation.  
9. Cryopreservation of the musculoskeletal tissues 
The musculoskeletal tissue cryopreservation process at - 80◦C is described in chapter 1 
(VALIDATION OF PRIMARY PACKAGING FOR CRYOPRESERVED 
MUSCULOSKELETAL TISSUES) 
10. Lyophilization of musculoskeletal tissue 
The bones can also be processed in their lyophilized form. The lyophilization process should 
be validated and be, like all the tissue handling procedures, in conformity with the Manual 
of Good Manufacturing Practice - GMP and in accordance with international standards6, 
literature7 and legislation. The procedure involves the use of an automated lyophilization 
system composed of a Labconco® (Illustration 11) freeze drying, or lyophilization chamber 
with Condensation Chamber/Vacuum. During lyophilization the tissues remain frozen for 
the prevention of ice crystal liquefaction inside the matrix. The sublimation process should 
be validated by analyses of the Residual Moisture by automated thermogravimetric method. 
The lyophilization process is divided into 2 stages: Primary and Secondary Drying. In the 
primary phase, the largest fraction of water present in the matrix in its solid state (ice 
crystals) is removed by sublimation induction and gaseous migration. This induction is 
achieved by the driving force resulting from the difference of pressure gradient between the 
lyophilization chamber and condenser. The heat generated by this gaseous transportation 
should be controlled continually by digital sensors strategically positioned inside the 
lyophilization chamber. 
At the end of the sublimation, the aliquot of unfrozen water linked to the organic 
components of the matrix (proteins) is then removed in the secondary phase, with an 
increase of pressure in the lyophilization chamber followed by the gradual increase of 
temperature at positive levels.  
The analysis and control of residual moisture are essential to ensure the integrity of the 
protein matrix. The residual moisture is determined by thermogravimetric method, using an 
Ohaus® (Illustration 12,13) moisture analyzer.  This method analyzes the initial weight of 
the sample on precision scales, followed by the promotion of heating with continuous 
recording of evaporation and weight. The percentage of residual moisture (RM), solid mass 
(SM), initial weight (IW) and final weight (FW) are analyzed in this method. The limit of 
RM is < 6 % as described by literature (Phillips, 2000). 
                                                                          
6European Association of Tissue Banks. Common Standards for Tissues and Cells Banking: Berlin: 
European Association of Tissue Banks; 2004. 
American Association of Tissue Banks. Standards for Tissue Banking. 11th ed. McLean : American 
Association of Tissue Banks; 2007 
7 Phillips GO, Strong DM, Versen RV, Nather A.  Advances in Tissue Banking. Vol. 4. World Scientific . 
New Jersey, 2000. 
Bancroft JD, Stevens A. Theory and practice of histological techniques. Fourth Edition. Churchill 
Livingstone.  United Kingdom, 1999. 
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Illustration 11. Lyophilization chamber: Labconco® equipment from the Tissue Bank of 
Hospital das Clínicas – Universidade de São Paulo. 
   
Illustrations 12,13. Residual Moisture Analyzer: Ohaus® equipment belonging to the Tissue 
Bank of Hospital das Clínicas – Universidade de São Paulo. 
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The result of the lyophilization is a dry tissue, conservable at room temperature and that should 
receive final sterilization by radiation. The lyophilized tissue radiation process is carried out in a 
Multi-purpose Irradiator, with gamma radiation from sources of 60CO. The appropriate radiation 
dose is 25 kGy, with a dose rate of approximately 7 kGy/h. In order to avoid temperature 
variation, the samples are radiated in the presence of cooling elements, keeping the temperature 
between 4 and 8 °C. Red Perspex dosimeters are used for dose control. 
 
Time Interval Process Indicators Sample 
Temperature  
2 hours Pre-freezing of the 
lyophilization 
chamber 
Temp. Chamber:  – 40 ◦C – 80 ◦C 
10 minutes Vacuum  Chamber Temp.:  – 30 ◦C 
Chamber Vacuum : 8 x 10 -3 
mBar 
Condenser Vacuum : 2 x 10 -3 
mBar 
– 65 ◦C 
6 hours Primary Drying Chamber Temp.:  – 30 ◦C 
Chamber Vacuum: 8 x 10 -3 
mBar 
Condenser Vacuum : 1 x 10 -3 
mBar  
Analysis Final Moisture of 
Phase 01 
RM: 6.26% 
Initial Weight: 0.527g 
Final Weight: 0.494g 
Solid: 93.74% 
Analysis Temperature: 105◦C 
 
– 40 ◦C 
4 hours Secondary Drying Chamber Temp.: up to + 5 ◦C 
 
Chamber Vacuum: 7 x 10 -3 
mBar 
Condenser Vacuum: 1 x 10 -3 
mBar  
 
 
Analysis Final Humidity of 
Phase 02 
RM: 2.32% 
Initial Weight: 0.732g 
Final Weight: 0.715g 
Solid: 97.68% 
Analysis Temperature: 105◦C 
+ 5 ◦C 
 
Table 1. Primary and Secondary Drying Process 
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11. Storage, distribution and quality control of tissue 
At the end of any processing mode, the procedures should be documented in a specific file. 
This file is used to contain all the documentation related to the process, including records of 
the participant team, inputs used, documents evidencing sterility of instruments and other 
records that are part of the quality control program and that provide subsidies for 
traceability of the processes. This stage is imperative in the legislation and recommended by 
the Standards and Quality Control Manuals. 
The tissue stock can be kept both frozen and at room temperature (lyophilized) following 
the same standards used by the global tissue banks and associations. Other processing 
methods have been investigated with the purpose of reducing the costs related to banking 
and maintenance. The glycerolization of bone tissue is presented as a processing 
methodology able to maintain the viability of the matrix and to prevent bacterial growth, 
besides enabling storage at room temperature (Giovani, 2006). 
Until the transplantation occurs, all the processed tissues should be submitted to rigid 
quality assurance criteria. It is necessary to have an evaluation of all the data pertaining to 
the donor, results of exams, maintenance and control of equipment, material and 
instruments used in all the phases of each procedure. Management software can be used to 
record all the stages, allowing the fast retrieval of information such as the particulars of the 
donor, lot, shelf life, exams and status of the tissue (analysis, released, excluded, used) 
making it easier to trace each graft processed and made available, especially in the presence 
of evidence of an adverse effect and implementation of corrective and preventive actions. 
For a lot of grafts under analysis to be released for use, the qualified technical professional 
from the Tissue Bank must analyze the results of all the exams performed: NAT or PCR 
serology for HIV, HBC and HCV, General Culture, Anaerobic Culture, Fungal Culture, 
Anatomopathological Exam and radiology reports. These exam reports are ultimately 
evaluated and released by the Qualified Clinical Professional of the service.  
Besides exams, it is necessary to consider an evaluation of the printed records of 
temperature during the banking period. The service should have equipment that detects 
temperature oscillations even at a distance (satellite monitoring system). 
Moreover, the installation of buzzers at strategic points of the hospital as well as Co2 
backups ensures the reliability of the system. 
After the release of each lot, there should also be a final inspection of each tissue, besides the 
substitution of tags of tissues under analysis by replaced. The banking logistics of the tissues 
in the ultra-low temperature (ULT) freezers considers the tissue type and search agility.  
Services that execute rigorous quality control use annotation systems featuring checklists 
with double checking and consent.  
All the data pertaining to the donor and to the lot, in compliance with the legislation, should 
be kept in single folders and stored in specific files of the musculoskeletal tissue bank for a 
minimum period of 25 years. 
A serum bank with samples of donor plasma should also be made available by the 
musculoskeletal tissue bank in case of the need for counterproof exams. 
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As soon as the quality criteria have been evaluated and approved, the tissues are made 
available for use. 
The tissues are distributed to the various specialties (Hip, Knee, Shoulder, Tumors and 
Dentistry) according to the availability of and requests for grafts.  
The transplanter (physician or dentist) places the order for the tissue through a discussion of 
cases and by sending a specific form. The tissue reservation takes into account the demand 
for each type of transplant, waiting list and stock. The waiting list for transplantations 
performed within the Unified Health System - SUS complies with the prevailing legislation 
and today is organized and managed by the musculoskeletal tissue banks themselves, 
observing an order by date of inclusion. Urgent cases appointed by the medical team, such 
as malignant tumors and situations with a risk of severe complications, are communicated 
to the musculoskeletal tissue bank through an Emergency Form, for immediate response. 
In dentistry, transplants have evolved differently and their distribution features some 
particularities that will be described further on. 
12. Global data on tissue transplantation activities in Brazil 
Today it can be seen that tissue transplantations in general are on the rise. Events such as 
officialization in the legislation and the creation of public promotion policies corroborate 
this evolution. Considering bone transplants alone, 30x growth has been observed in the last 
5 years (Brazilian Transplantation Register, 2010), a fact motivated by the start of large-scale 
distribution of tissues for dental surgery. Although statistics show the number of tissues to 
be growing, the quantity of donors is still a concern. The vast majority of donors in Brazil 
are still for the removal of perfused solid organs (heart, kidney, liver, etc. A minority (6% on 
an average) accept the donation of musculoskeletal tissues. Of these, just 8% on average, 
become effective donors and the rest are discarded due to the presence of exclusion criteria 
such as infections, blood transfusion, and inadequate profile (Graph 1). 
 
Graph 1. Reasons for refusals of bone donors between 2006-2010. 
(Source: File BTME-HC-USP) 
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13. Homologous tissue transplants in dentistry 
Dentistry has also sought biomaterials usable in the replacement of mandibular and 
maxillary bone loss over the years. The transplantation of bone portions taken from the iliac 
crest and menton (autologous transplant) has been broadcast in recent years, yet similarly to 
what happened in the orthopedic area, the disadvantages related to donor morbidity and 
the good results observed in the use of allografts in orthopedic patients, motivated 
professionals and patients to adopt this form of treatment. 
In Brazil the use of bone transplants in dentistry started in 2005 after a consensus regarding 
the need for use and administrative mobilizations with the National Transplant System, 
Federal Council of Dentistry and Musculoskeletal Tissue Banks. This consensus serves as a 
starting point for the definition of criteria for requests for these tissues at the existing banks, 
where the professional must be a specialist in the areas of Implant Dentistry, Periodontics or 
Oral and Maxillofacial. 
Rules related to logistics and traceability were incorporated into the activities of existing 
tissue banks, which then started to implement the bone tissue processing and distribution 
programs for dental purposes. In this program it is crucial to record the entire process with a 
focus on health control, including adverse deeds and traceability from the request to the 
actual transplantation. Specific forms are used for this purpose, including the Request Form, 
Terminated Transplantation Form, Non-Conformity Term and Adverse Effect Form. 
Once standardized, this type of transplant is initiated in the country with widespread 
adoption by dentists, as observed in the Brazilian transplantation records. (RBT, 2006-2010) 
Naturally, the Maxilla and Mandible are today the main bone tissue receptor areas in 
dentistry that have very distinctive characteristics when submitted to the osteolysis 
processes, which, in turn, require distinctive techniques during the bone transplant. The size 
and shape of the bones are influenced by several factors, which range from the genetic 
conditions of the individual to the environment in which they live. In other words, age, sex, 
physical characteristics, health, diet, race and place of residence are aspects to be considered 
(Moore, 1990). 
Maxillary and Mandibular development and growth are determined by the appearance of 
teeth from the first months of life. It is interesting to note that the mandibular and maxillary 
bone tissue responds to intrinsic and extrinsic factors throughout the lifetime of an 
individual, and, therefore is very plastic, which counteracts its rigid and inert appearance.  
 
Pathophysiology of Bone Loss 
Metabolic Factors: 
  Age; 
  Gender; 
  Hormone balance; 
  Osteoporosis; 
  Nutritional disorders. 
Mechanical Factors: 
 Functional (force applied to edge (pressure, compression, tension, 
shearing)): 
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 Frequency; 
 Direction; 
 Quantity. 
Prosthetic Factors: 
 Type of prosthesis base; 
 Shape and type of teeth. 
Table 2. Factors related to the bone loss process (Source: Fonseca & Davis, 1995) 
One of the factors most closely related to the indication of bone reconstructions in dentistry 
are maxillary and mandibular resorptions due to lack of the dental element.  
The resorption of the alveolar edge is a chronic, progressive, irreversible and cumulative 
alteration. This condition, observed in the toothless individual, becomes faster in the first six 
months after exodontias or dental extractions. Once the function of providing support to the 
teeth has been lost, the alveolar process tends to undergo resorption due to disuse (Mecall & 
Rosenfeld, 1991). And this resorption can be exacerbated by local factors (traumatism, 
infections and pathologies), systemic factors (osteopenia, osteoporosis, osteomalacia, 
endocrine and nutritional alterations), systemic health problems, prosthetic treatments and 
others (Fonseca & Davis, 1995; Gassen et al, 2008) 
Projections by the Brazilian Institute of Geography and Statistics (IBGE) show that the 
elderly population in Brazil is set to increase considerably in future years. Life expectancy in 
2020 is estimated at 71.2 years (men) and 74.7 years (women) and will represent 13% of the 
population (IBGE, 2011). Data from the Epidemiological Survey indicate the elderly age 
bracket as having the highest rates of edentulism and of prosthesis use for prolonged 
periods. (Ministério da Saúde, 2003) 
The previous use not only of total prostheses but also of removable partial prostheses is 
identified as a predisposing factor of tissue resorption (odds ratio = 2.4), and the flaccid 
tissue from the edge is related to the severity of resorption (odds ratio = 2.4). (Watzek, 1996, 
Xie et al, 1997) 
In this context, it is noted that the majority of atrophic edentulous cases (total or partial) has 
increasingly resorted to the adoption of dental implants and for this reason, bone grafts 
appear as an option of biomaterial used in pre-prosthetic surgery (Galea, 2005). 
Frozen homologous bone tissue is biocompatible and can be used successfully in treatments 
that require maxillary sinus lifting. Its use favors bone neoformation, integration, and 
absence of inflammatory infiltrate as well as an increase in the percentage of bone volume 
(Stacchi et al, 2008). In the long term, it is possible to observe the formation of viable and 
mature bone tissue, providing adequate reconstruction techniques are adopted. (Contar et 
al, 2009) 
Some studies in the dental area have evaluated the efficacy of the use of allografts through 
an analysis of the biomechanics of implants placed in the grafting zone. This is possible 
through a resonance frequency analysis (RFA) and removal torque (RT) analysis. The results 
show that there is no difference in stability between implants installed with autogenous and 
allogeneic grafts. (Ribeiro, 2009) It is also possible to evaluate the osseointegration process 
through an evaluation of the neoformed bone volume. Lima (2010) studied homologous 
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bone grafts processed in a tissue bank with different methods (lyophilized, demineralized 
and radiated (ALD); mineralized frozen (ACM) besides autogenous grafts (AT) and blood 
clot (CG). In the Guided Bone Regeneration (GBR) technique, samples of the groups of 
grafts were placed in 32 cylinders fastened to the calvaria of 08 animals. After 13 weeks the 
cylinder fill rates (bone volume of the ALD group) were similar to the ACM and superior to 
the autogenous graft). Bone neoformation also occurs during the use of homologous grafts 
in maxillary sinus lifting surgery, besides affording lower morbidity levels (Viscioni et al, 
2010). Hence it should be considered a valid alternative for the replacement of autologous 
grafts in patients submitted to implant therapy. 
14. Prospects in the application of osseointegration investigation 
methodologies in grafting areas 
Some techniques can be used today in the analysis of interface sites between receptor and 
donor bone, which generate information capable of providing subsidies for a greater 
understanding of the osseointegration process. 
14.1 Histomorphometry 
Histomorphometry aims to analyze bone morphology and its components (measurements 
of volume, area, perimeter etc.). This technique is developed primarily for rock analysis, and 
is currently employed to analyze cellular behaviors of tissues starting from their structural 
conformity, expressed in thin slices on a slide. The histological reading and the definition of 
elements that compose the bone microtexture is the main goal of this procedure. The 
method can be manual, semiautomatic and automatic. A microscope coupled to a 
micrometer ruler is used in the first. In the semiautomatic version the microscope is coupled 
to a computer, which in turn uses software that allows users to record and to quantitatively 
analyze the images of a slide, seen through the microscope lenses, which are projected onto 
a digitizing board and drawn manually. The definition of each histological structure is 
performed by a professional. Finally, the automatic technique allows users to capture the 
images from the microscope using video cameras and the definition of each structure is 
determined by the actual computer, which automatically analyzes the coloration of each 
structure. Although the latter is the fastest technique, it is also the least sensitive. (Jorgetti, 
2003; Aaron, Shore, 2003) 
This technique permits the analysis of primary or static parameters (extension, number and 
distance) and the derived parameters, which are divided into structural (analyze bone 
structure) and kinetic (analyze the dynamics of the bone tissue). 
The histomorphometric parameters are measured at 125x zoom. The choice of the analysis 
area should consider the contact surface of the receptor bone with the allograft. 
A microscope equipped with objective, micrometer ruler, cursor, digitizing board and image 
analysis software is used to quantify the structural static, bone tissue formation and 
resorption histomorphometric parameters. (Illustration 22) 
The static histomorphometric parameters are classified as: 
STRUCTURAL PARAMETERS 
 Total area (T.Ar mm2): total area measured; 
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 Bone Volume (BV/TV %): percentage of bone tissue formed by mineralized or 
unmineralized trabecular bone; 
 Thickness of the woven bone (Tb.Th m): thickness of the bone trabeculae expressed in 
micra; 
 Trabecular number (Tb.N/mm): the number of bone trabeculae, by millimeter of tissue, 
which is also an index that expresses trabecular density; 
 Trabecular separation (Tb.Sp m): the distance between the bone trabeculae expressed 
in micra; 
 Number of osteocytes (N.Ot): number of osteocytes present in the area of the bone 
tissue evaluated. 
 
Illustration 14. Equipment used for histomorphometric analysis (microscope coupled to 
digitizing board and Osteomeasure® software) 
FORMATION PARAMETER 
 Osteoid volume (OV/BV %): percentage of osteoid matrix in relation to the trabecular 
bone; 
 Osteoid surface (OS/BS %): percentage of trabecular surface covered by osteoid matrix; 
 Osteoblast surface (Ob.S/BS %): percentage of the trabecular surface that presents 
osteoblasts; 
 Osteoid thickness (O.Th m): the thickness of the osteoid matrix deposited on the bone 
trabeculae, expressed in micra; 
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 Number of osteoblasts (N.Ob): absolute number of osteoblasts present in the measured 
area; 
 Number of osteoblasts by tissue area (N.Ob/T.Ar): number of osteoblasts by tissue area 
analyzed, expressed in square millimeters; 
 Number of osteoblasts by bone perimeter (N.Ob/B.Pm): number of osteoblasts by bone 
perimeter analyzed, expressed in millimeters. 
RESORPTION PARAMETER 
 Osteoclast surface (Oc.S/BS%): percentage of trabecular surface that presents 
osteoclasts; 
 Number of osteoclasts (N.Oc): number of osteoclasts present in the area of the bone 
tissue evaluated; 
 Resorption surface (ES/BS %): percentage of surface that presents bone resorption 
lacunae with or without the presence of osteoclasts. 
The histomorphometric parameters adopted in this technique should follow a universal 
nomenclature agreed upon by the American Society of Bone and Mineral Research - ASBMR 
(Parfitt et al., 1987).  
14.2 Immunohistochemistry 
With the advent of osseointegrated dental implants it is extremely important for us to know 
the cellular processes involved in the osseointegration of allografts, as already mentioned, 
and this is possible with the immunohistochemistry technique. In vivo mineralization on the 
implant surface is directly related to the components of the extracellular bone matrix, both 
collagen and non-collagen components. The bone structure is composed of about 70% of 
inorganic matter (hydroxyapatite), while the rest is the organic matrix, predominantly 
consisting of collagen (95%), which is responsible for its flexibility and resistance whereas 
type I collagen provides support to the mineral structure. The non-collagen components 
include osteocalcin, osteonectin and osteopontin. 
Osteocalcin is related to bone matrix mineralization, and is exclusively expressed by 
osteoblasts (Ducy et al. 1995). Osteonectin influences the synthesis of extracellular matrix 
components (Bradshaw et al. 2003) and the calcification of the organic matrix as it is 
selectively linked to hydroxyapatite and type I collagen fibrils (Termine et al. 1981). 
Osteopontin is strongly linked to hydroxyapatite crystals and is involved in the anchoring of 
the osteoclasts in the inorganic bone matrix, controlling crystal nucleation and growth. 
Hence the evaluation of these proteins in the osseointegration process can provide us with 
important information about how the allogeneic bone graft used can corroborate for better 
interaction of the cellular mechanisms between donor and recipient focusing on the 
maintenance of the bone tissue after the implant installation. 
Moreover, the remodeling of this matrix needs specialized enzymes. Matrix 
metalloproteinases (MMPs) are an important family of endopeptidases, with 25 known 
human members, and represent the largest class of enzymes that, collectively, are 
responsible for the degradation or resorption of extracellular matrix components, and are 
the only enzymes capable of cleaving fibrillar collagens (Curran et al. 1999), several proteins 
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from the cellular surface and from the pericellular environment and some intracellular 
proteins.  
This technique makes it possible to evaluate bone matrix proteins (type I collagen, 
osteocalcin, osteopontin and osteonectin) and the MMPs during the osseointegration 
process of bone grafts in patient to be submitted to future dental implants. 
14.3 Peripheral quantitative computed bone tomography (pQCT) 
Peripheral quantitative computed tomography - pQCT is a method used to measure the 
appendicular skeleton that, besides furnishing a broad range of data, also makes it possible 
to evaluate the cortical and trabecular bones separately. 
The obtainment of images is performed by a scanner (ex Stratec XCT Research M instrument 
scanner (Norland Medical Systems, Fort.) specifically for the analysis of small grafting sites. 
The parameters evaluated in this technique are: 
- total BMC – total bone mineral content, mg/mm; 
- total BMD - total bone mineral density, mg/cm3; 
- trabecular BMC - trabecular mineral content, mg/mm; 
- trabecular BMD - trabecular mineral density, mg/cm3;  
- cortical content, mg/mm; 
- cortical density, mg/cm3; 
- total area, mm2; 
- trabecular area, mm2. 
- periosteal circumference, mm; 
- endosteal circumference, mm. 
15. Discussion 
There have been many differences in bone tissue preparation techniques since the first tests 
in the 30s, yet the desire for the recovery of lost bone tissue among physicians and dentists 
still remains. The Ministry of Health has recently expressed interest in increasing and 
promoting this kind of transplant in the country. It is a fact that an increasing number of 
patients with bone loss for various reasons have approached specialized orthopedics and 
dentistry services in pursuit of reconstructive solutions. This context includes procedures 
involving the use of allografts made available by musculoskeletal tissue banks. 
In dentistry, the officialization of allograft use arrives very late in 2005. Dental transplanters 
were curtailed in their use of this kind of treatment for more than a decade. Public policies 
of oral health were also very late in arriving. The result is perceptible in the statistics that 
evidence a high rate of edentulism in our population. (Ministerio da Saúde, 2003). In 
response to this situation, we can also observe high rates of prosthetic rehabilitations in the 
Brazilian population. 
Data from the Epidemiological Oral Health Survey in Brazil (2003) shows that about 67% of 
the population between 65 and 74 years of age use some kind of prosthesis as a form of 
edentulism treatment. We know that edentulism and the prolonged use of these prostheses 
lead to maxillary and mandibular bone resorption over the years (Davis, 1995; Gassen et al, 
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2008). The high rate of individuals with this necessity, the greater economic access of the 
population to treatments with osseointegrated implants and to the start of authorization of 
allograft use in dentistry, corroborated the abrupt growth of bone transplants in dentistry at 
around 600% in these last 5 years (Graph 2).  
 
Graph 2. Annual Distribution of homologous tissues made available by a tissue bank that 
serves as a national reference for Dental Transplants (2006 to 2010). 
Such a situation was also observed in our study in relation to the number of transplanting 
dentists, whose number climbed steeply from 22 to 3585 also in 5 years (Graph 3).  
 
Graph 3. Absolute Frequency of dentists accredited for transplants over the years (2006-
2010) 
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In the next few years we will observe growth of the elderly population in our country 
(around 13% in 2020), motivated by the increase in life expectancy. It is estimated that in 
2020 this expectancy will be 71.2 years for men and 74.7 years for women (IBGE, 2011). 
Considering that the elderly population is exposed to factors accumulated during their 
lifetimes that lead to the need for pre-prosthetic reconstructive bone interventions 
(edentulism, prolonged use of prostheses, osteoporosis, hypothyroidism) we can reflect here 
on a possible influence over prosthetic rehabilitations of the elderly population in future 
years, and that in some of them the use of biomaterials (including allograft) may be 
indicated. 
What then has become an obvious trend gives rise to the need to discuss the future of dental 
transplants. Public health surveillance policies seek, together with trade associations 
(Regional Federal Council of Dentistry) and tissue banks, the assurance of traceability in 
procedures of this nature. This is undoubtedly the major challenge for tissue banks. Unlike 
other kinds of transplants, where the data are compiled and made available by hospitals, in 
dental transplantations there is the need for total involvement of the transplanting 
professional in disclosing and informing the adverse effects detected in the treatment. 
Following the example of the national policy implemented by ANVISA in the area of 
hemoderivates transfusion, the intention is to create a similar system for the surveillance of 
tissue transplants in the country, which will include dental transplants. In this model, the 
adverse effects can be notified nationwide (electronically), enabling the construction of a 
database that will serve as a source for the definition of corrective and preventive actions of 
complications in dental surgeries with the use of allografts. Such information is extremely 
valuable to banks, particularly in the quality control of the tissues produced thereby. 
After a more detailed analysis of dental transplants, we detected that approximately 76% are 
related to the use of cortical tissues, which in our understanding is expected due to the 
greater availability of this type of tissue at banks. While a spongy segment of a long bone 
such as the femur and tibia (metaphyseal region) yields 10 to 15 units of spongy blocks, 50 to 
60 units of cortical blocks are processed from a diaphysis. It should also be considered that 
due to the lesser availability of spongy tissues, surgeons have opted in particular for cortical 
blocks, especially for use in sinus lifting surgery preceding implant installation. 
 
GRAFT MORPHOLOGY Relative Frequency  (%) 
Cortical 75.64 % 
Spongy 15.86 % 
Cortico-Spongy 8.5 % 
TOTAL 100.00 
Table 3. Distribution of Grafts in Terms of Morphology. BTM (musculoskeletal tissue bank) - 
HCFMUSP, 2006 to 2010. 
The most frequent surgical site was undoubtedly the maxilla (98.2%- Graph 4) and we 
hereby emphasize the main reasons for this finding. Firstly, edentulism in the Brazilian 
population has appeared to affect the maxilla more than the mandible which certainly leads 
to the greater use of upper prostheses (57.9%) versus lower prostheses (34.18%) by the 
population aged between 65 and 74 years (Ministério da Saúde, 2003). Secondly, the actual 
anatomy of the maxilla due to the presence of maxillary sinuses that are grafted during the 
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sinus lifting technique. This technique is very frequent in the branch in implant dentistry. 
Thirdly, the lower bone quality of the maxilla in comparison to the mandible, focusing on 
the primary stability of implants and propensity for resorption after the prolonged use of 
prostheses. (Mezzomo et al, 2010) It is also worth emphasizing that the maxilla appears as a 
more esthetic area that demands more attention from individuals concerned about its 
rehabilitation. 
Graph 4. Distribution of Type and Surgical Site of use of the tissues made available by a 
bank that serves as a national reference from 2006 to 2010. 
Although epidemiological data shows the increasing use of homologous tissues in dental 
surgery, few studies in our field assess their efficacy, hence the need to establish consensuses on 
their applicability and more importantly, predictability of treatments with the use of allografts. 
We take predictability to mean knowledge of the responses of bone tissue to the interventions 
performed in our areas of specialty. Thus in this study we have highlighted a chapter on possible 
lines of investigation enforceable in our field, which can help us in our search for answers related 
to the osseointegration process of allografts at sites of dental interest.  
The analysis of grafting area by histomorphometry allows us to accurately quantify the 
structure of the grafted tissue (area, volume) and how much tissue was formed after 
interaction with the recipient’s body (osteoid volume, osteoid surface), to judge the 
participation of each bone cell (number of osteoblasts and osteocytes) and also to quantify 
resorptions that have occurred (resorption surface) as a result of this interaction. This data is 
supplemented by peripheral quantitative computed tomography – pQCT, which unlike 
histomorphometry, allows us to evaluate the density of the tissue before and after the 
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grafting period. Data of extreme importance, in view of the need for assurance of 
mechanical stability of dental implants, when implanted in the newly formed bone. 
And finally, immunohistochemistry solves some mysteries related to the cellular processes 
involved in osseointegration. The technique allows us to evaluate, by means of reaction by 
selected antibodies, the expression of proteins related to the mineralization process 
(osteocalcin, collagen) and remodeling of bone grafts (osteopontin, osteonectin). 
As the basis for all these cellular events, the use of specific antibodies (Tartrate-resistant Acid 
Phosphatase - TRAP, Osteoprotegerin, Rank-L and Cd34) also allows us to evaluate the 
inflammation and the vascularization of grafting areas throughout the osseointegration period. 
Nowadays in Brazil we are experiencing a time of transition in the indication of these 
transplants, and studies with this information content are certainly necessary for better 
knowledge and indication of allografts in dentistry, as well as the criteria and 
methodologies that can be used to analyze osseointegration. 
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